Safety and Efficacy of Eltrombopag (EPAG) at Doses up to 150 mg/day in Children with Chronic Immune Thrombocytopenia (cITP) Who did not Achieve Target Platelet Counts (PLTS) with 75 mg/day dose-MedSci.cn

Safety and Efficacy of Eltrombopag (EPAG) at Doses up to 150 mg/day in Children with Chronic Immune Thrombocytopenia (cITP) Who did not Achieve Target Platelet Counts (PLTS) with 75 mg/day dose

Keefe, P; Rocha, A; Bussel, J

PEDIATRIC BLOOD & CANCER, 2017; 64 ( ): S10

科室
- - 订阅+
  - 更多科室
工具
服务